TAKEDA PHARMACEUTICALS AMERICA, INC.

Proposals related to health equity, including but not limited to: clinical trial diversity, issues of patient assistance programs, and social determinants of health; Proposals related to drug pricing, drug price transparency, PBMS; Discussions on value-based contracting E.O. 13937, Access to Affordable Life-Saving Medications; E.O. 13938, Increasing Drug Importation to Lower Prices for American Patients; E.O. 13939, Lowering Drug Prices by Eliminating Kickbacks to Middlemen; E.O. 13947, 13948, Lowering Drug Prices by Putting America First; E.O. 13944, Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs are Made in the United States; Issues related to plasma derived therapies; Implementation of the Inflation Reduction Act; Reauthorization of the Pandemic All Hazards Preparedness Act